06:40 EDT Cingulate files to sell 1M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CING:
- Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
- Cingulate issued European patent for CTx-1301 for ADHD
- Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones Achieved
- Cingulate sees cash runway late into 3Q24
- Cingulate reports Q2 EPS ($5.47) vs. ($6.79) last year